학술논문
Randomized, double-blind, phase 3 trial of enzastaurin versus placebo in patients achieving remission after first-line therapy for high-risk diffuse large B-Cell lymphoma
Document Type
Article
Author
Crump, M.; Savage, K.J.; Leppä, S.; Fayad, L.; Schnell, F.; Rifkin, R.; Pinter-Brown, L.; Smith, S.; Hsi, E.D.; Nguyen, T.; Shi, P.; Hahka-Kemppinen, M.; Thornton, D.; Lin, B.; Kahl, B.; Habermann, T.; Lee, J.J.; Rocco, A.D.; Ogura, M.; Tobinai, K.; Hagberg, H.; MacKensen, A.; Schmitz, N.; Offner, F.; Yeh, S.-P.
Source
In: Journal of Clinical Oncology . (Journal of Clinical Oncology, 20 July 2016, 34(21):2484-2492)
Subject
Language
English
ISSN
15277755
0732183X
0732183X